ASRT - Public offerings

LAKE FOREST, Ill., Aug. 25, 2022 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. ("Assertio" or the "Company") (NASDAQ:ASRT), a specialty pharmaceutical company offering differentiated products to patients, today announced that it has closed its offering of $70 million aggregate principal amount of 6.50% convertible senior notes due 2027 (the "Convertible Notes"), including the full exercise of the option to purchase $10 million of additional notes granted by Assertio to the initial purchaser (the "Offering"). The notes were issued in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the "Securities Act"). The Offering is e

LAKE FOREST, Ill., Feb. 12, 2021 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (NASDAQ: ASRT) today announced that it closed its previously announced registered direct of common stock at a purchase price of $0.98 per share for gross proceeds of approximately $34.3 million. Roth Capital Partners acted as the sole placement agent in connection with the offering. After the placement agent fees and estimated offering expenses payable by the company, the company received net proceeds of approximately $32.1 million. The Company intends to use the net proceeds from the offering for general corporate purposes, including general working capital. The securities describ

LAKE FOREST, Ill., Feb. 10, 2021 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (NASDAQ: ASRT) today announced it has entered into a securities purchase agreement with certain institutional investors to purchase 35,000,000 shares of its common stock at a price of $0.98 per share, which is a premium to market based on applicable Nasdaq “minimum price” rules. Roth Capital Partners acted as the sole placement agent in connection with the offering. The registered direct offering is expected to close on February 12, 2021, subject to customary closing conditions. The gross proceeds to the Company from the registered direct offering are estimated to be app

LAKE FOREST, Ill., Feb. 09, 2021 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (NASDAQ: ASRT) today announced that it closed its previously announced registered direct of common stock at a purchase price of $0.62 per share for gross proceeds of approximately $14.0 million. Roth Capital Partners acted as the sole placement agent in connection with the offering. After the placement agent fees and estimated offering expenses payable by the company, the company expects to receive net proceeds of approximately $13.0 million. The Company intends to use the net proceeds from the offering for general corporate purposes, including general working capital. The se

LAKE FOREST, Ill., Feb. 05, 2021 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (NASDAQ: ASRT) today announced it has entered into a securities purchase agreement with certain institutional investors to purchase 22,600,000 shares of its common stock at a purchase price of $0.62 per share in a registered direct offering.   Roth Capital Partners acted as the sole placement agent in connection with the offering. The offering is expected to close on February 9, 2021, subject to customary closing conditions. The gross proceeds to the Company from the registered direct offering are estimated to be approximately $14.0 million before deducting the placement agent’s fee